Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1972 1
1973 1
1975 1
1976 1
1977 4
1978 1
1980 3
1982 2
1983 1
1984 2
1985 9
1986 1
1987 8
1988 10
1989 5
1990 24
1991 32
1992 26
1993 29
1994 32
1995 31
1996 43
1997 45
1998 58
1999 88
2000 62
2001 61
2002 70
2003 75
2004 75
2005 86
2006 135
2007 122
2008 136
2009 150
2010 169
2011 216
2012 237
2013 221
2014 276
2015 214
2016 220
2017 253
2018 317
2019 271
2020 282
2021 290
2022 248
2023 227
2024 79

Text availability

Article attribute

Article type

Publication date

Search Results

4,493 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Immunodeficiency 66"
Page 1
An immunologist's perspective on anti-COVID-19 vaccines.
Milota T, Strizova Z, Smetanova J, Sediva A. Milota T, et al. Curr Opin Allergy Clin Immunol. 2021 Dec 1;21(6):545-552. doi: 10.1097/ACI.0000000000000788. Curr Opin Allergy Clin Immunol. 2021. PMID: 34545040 Review.
PURPOSE OF REVIEW: Antisevere acute respiratory syndrome-corona virus 2 (SARS-CoV-2) vaccines may provide prompt, effective, and safe solution for the COVID-19 pandemic. Several vaccine candidates have been evaluated in randomized clinical trials (RCTs). Furthermore …
PURPOSE OF REVIEW: Antisevere acute respiratory syndrome-corona virus 2 (SARS-CoV-2) vaccines may provide prompt, effective, and safe soluti …
Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial.
Marzinke MA, Hanscom B, Wang Z, Safren SA, Psaros C, Donnell D, Richardson PA, Sullivan P, Eshleman SH, Jennings A, Feliciano KG, Jalil E, Coutinho C, Cardozo N, Maia B, Khan T, Singh Y, Middelkoop K, Franks J, Valencia J, Sanchez N, Lucas J, Rooney JF, Rinehart AR, Ford S, Adeyeye A, Cohen MS, McCauley M, Landovitz RJ, Grinsztejn B; HPTN 083 study group. Marzinke MA, et al. Lancet HIV. 2023 Nov;10(11):e703-e712. doi: 10.1016/S2352-3018(23)00200-X. Epub 2023 Sep 29. Lancet HIV. 2023. PMID: 37783219 Clinical Trial.
We aimed to characterise the cohort of transgender women included in HPTN 083. METHODS: HPTN 083 is an ongoing, phase 2b/3, randomised, multicentre, double-blind, double-dummy clinical trial done at 43 sites in seven countries (Argentina, Brazil, Peru, the US …
We aimed to characterise the cohort of transgender women included in HPTN 083. METHODS: HPTN 083 is an ongoing, phase 2b/3, randomised …
Biologic Agents and Secondary Immune Deficiency.
Axelrod H, Adams M. Axelrod H, et al. Pediatr Clin North Am. 2019 Oct;66(5):1007-1020. doi: 10.1016/j.pcl.2019.06.009. Epub 2019 Aug 5. Pediatr Clin North Am. 2019. PMID: 31466676 Review.
Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks.
Riedl MA, Maurer M, Bernstein JA, Banerji A, Longhurst HJ, Li HH, Lu P, Hao J, Juethner S, Lumry WR; HELP Investigators. Riedl MA, et al. Allergy. 2020 Nov;75(11):2879-2887. doi: 10.1111/all.14416. Epub 2020 Jul 6. Allergy. 2020. PMID: 32452549 Free PMC article. Clinical Trial.
Intrapatient comparisons for days 0-69 versus steady state (days 70-182) used a paired t test for continuous endpoints or Kappa statistics for categorical endpoints. RESULTS: One hundred twenty-five patients were randomized and treated. During days 0-69, mean monthly attac …
Intrapatient comparisons for days 0-69 versus steady state (days 70-182) used a paired t test for continuous endpoints or Kappa statistics f …
Common variable immunodeficiency-associated granulomatous and interstitial lung disease.
Prasse A, Kayser G, Warnatz K. Prasse A, et al. Curr Opin Pulm Med. 2013 Sep;19(5):503-9. doi: 10.1097/MCP.0b013e3283642c47. Curr Opin Pulm Med. 2013. PMID: 23880700 Review.
PURPOSE OF REVIEW: Common variable immunodeficiency (CVID) is the most common primary immunodeficiency characterized by a deficiency of immunoglobulins. ...Prednisone treatment is often used as the first-line treatment and studies suggest response to treatmen …
PURPOSE OF REVIEW: Common variable immunodeficiency (CVID) is the most common primary immunodeficiency characterized by a d …
Humoral Immunodeficiency and Immune Globulin Replacement Therapy (IGRT) Usage in DiGeorge Syndrome.
Soshnick SH, Joseph T, Bennett NJ. Soshnick SH, et al. J Clin Immunol. 2021 Aug;41(6):1208-1212. doi: 10.1007/s10875-021-01012-8. Epub 2021 Mar 19. J Clin Immunol. 2021. PMID: 33740168
PURPOSE: An analysis of patients in the United States Immunodeficiency Network (USIDNET) registry previously described a discordance in the reported prevalence of humoral immune deficiency in patients with DiGeorge syndrome (DGS) and its treatment. The primary purpo …
PURPOSE: An analysis of patients in the United States Immunodeficiency Network (USIDNET) registry previously described a discordance …
Characteristics of Kenyan women using HIV PrEP enrolled in a randomized trial on doxycycline postexposure prophylaxis for sexually transmitted infection prevention.
Oware K, Adiema L, Rono B, Violette LR, McClelland RS, Donnell D, Scoville CW, Odoyo J, Baeten JM, Bukusi E, Stewart J. Oware K, et al. BMC Womens Health. 2023 Jun 3;23(1):296. doi: 10.1186/s12905-023-02413-0. BMC Womens Health. 2023. PMID: 37270546 Free PMC article. Clinical Trial.
The use of doxycycline as a prophylaxis to prevent STIs is promising; however, clinical trials, to date, have only been conducted among men who have sex with men (MSM) in high-income settings. ...METHODS: This is an open-label 1:1 randomized clinical trial …
The use of doxycycline as a prophylaxis to prevent STIs is promising; however, clinical trials, to date, have only been conducted amo …
Tuberculosis and human immunodeficiency virus infection in developing countries.
Harries AD. Harries AD. Lancet. 1990 Feb 17;335(8686):387-90. doi: 10.1016/0140-6736(90)90216-r. Lancet. 1990. PMID: 1968123 Review.
In adults and children over 15 who had pulmonary TB, 78% had positive sputum smears for acid-fast bacilli. 66% had cavitation on chest radiography. Many people with TB and HIV infection have typical clinical and radiologic features. ...Chemotherapy of TB in Africans …
In adults and children over 15 who had pulmonary TB, 78% had positive sputum smears for acid-fast bacilli. 66% had cavitation on ches …
Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349).
Pettit AC, Phillips PPJ, Kurbatova E, Vernon A, Nahid P, Dawson R, Dooley KE, Sanne I, Waja Z, Mohapi L, Podany AT, Samaneka W, Savic RM, Johnson JL, Muzanyi G, Lalloo UG, Bryant K, Sizemore E, Scott N, Dorman SE, Chaisson RE, Swindells S; Tuberculosis Trials Consortium (TBTC) Study 31/AIDS Clinical Trials Group (ACTG) A5349 study team. Pettit AC, et al. Clin Infect Dis. 2023 Feb 8;76(3):e580-e589. doi: 10.1093/cid/ciac707. Clin Infect Dis. 2023. PMID: 36041016 Free PMC article. Clinical Trial.
BACKGROUND: Tuberculosis (TB) Trials Consortium Study 31/AIDS Clinical Trials Group A5349, an international randomized open-label phase 3 noninferiority trial showed that a 4-month daily regimen substituting rifapentine for rifampin and moxifloxacin for etham …
BACKGROUND: Tuberculosis (TB) Trials Consortium Study 31/AIDS Clinical Trials Group A5349, an international randomized open-la …
Low dose versus high dose stavudine for treating people with HIV infection.
Magula N, Dedicoat M. Magula N, et al. Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD007497. doi: 10.1002/14651858.CD007497.pub2. Cochrane Database Syst Rev. 2015. PMID: 25627012 Free PMC article. Review.
SEARCH METHODS: The comprehensive search strategy developed by the Cochrane HIV/AIDS Review Group was used to identify randomised controlled trials that compared the use of low dose versus high dose stavudine. ...Symptomatic hyperlactatemia was seen in the high dose arm of …
SEARCH METHODS: The comprehensive search strategy developed by the Cochrane HIV/AIDS Review Group was used to identify randomised con …
4,493 results